Respiratory infections for which general practitioners consider prescribing an antibiotic: A prospective study

Archives of Disease in Childhood

Volumn 92, Issue 7, 2007, Pages 594-597

  Harnden, Anthony ^a   Perera, Rafael ^a   Brueggemann, Angela B ^b   Mayon White, Richard ^a   Crook, Derrick W ^b   Thomson, Anne ^b   Mant, David ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CHILD; CONVALESCENCE; COUGHING; DISEASE DURATION; DISEASE SEVERITY; FEVER; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; POLYMERASE CHAIN REACTION; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RESPIRATORY VIRUS; VIRUS ETIOLOGY;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FAMILY PRACTICE; FEVER; HUMANS; INFANT; NASOPHARYNX; OPPORTUNISTIC INFECTIONS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; PROSPECTIVE STUDIES; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 34347366315     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2007.116665     Document Type: Article

References (15)

1. Standing Medical Advisory Committee Sub-Group on Antimicrobial Resistance. The path of least resistance, Report of the Standing Medical Advisory Committee Sub-Group on Antimicrobial Resistance. London: Department of Health, September 1998.
2. Sharland M, Kendall H, Yeates D, et al. Antibiotic prescribing in general practice and hospital admissions for peritonsillar abscess, mastoiditis, and rheumatic fever in children: time trend analysis. BMJ 2005;331:328-9.
3. Fahey T, Smucny J, Becker L, et al. Antibiotics for acute bronchitis. Cochrane Database Syst Rev 2004;(4):CD000245.
4. Marchant JM, Morris P, Gaffney JT, et al. Antibiotics for prolonged moist cough in children. Cochrane Database Syst Rev 2005;(4):CD004822.
5. Mant D. Can randomised trials inform clinical decisions about individual patients? Lancet 1999;353:743-6.
6. Jacobs B, Young NL, Dick FT, et al. Canadian Acute Respiratory Illness and Flu Scale (CARIFS): development of a valid measure for childhood respiratory infections. J Clin Epidemiol 2000;53:793-9.
7. Shepperd S, Perera R, Bates C, et al. A children's acute respiratory illness scale (CARIFS) predicted functional severity and family burden. J Clin Epidemiol 2004;57:809-12.
8. Boom R, Sol C, Salimans M, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 1990;28:495- 503.
9. Dingle KE, Crook D, Jeffery K. Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCR. J Clin Microbiol 2004;42(3):1003-11.
10. Therneau TM, Atkinson EJ. An introduction to recursive partitioning using the RPART routines, Technical report. Rochester, MN: Mayo Foundation, 1997.
11. Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus in children. Clin Infect Dis 2003;36:299-305.
12. Smitherman H, Caviness AC, Macias CG. Retrospective review of serious bacterial infection in infants with influenza A infection. Paediatrics 2005;115:710-18.
13. Okamoto S, Kawabata S, Terao Y, et al. The Streptococcus pyogenes capsule is required for adhesion of bacteria to virus-infected alveolar epithelial cells and lethal bacterial-viral superinfection. Infect Immun 2004;72(10):6068-75.
14. McCullers JA, Rehg JE. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002;186:341-50.
15. British Infection Society; British Thoracic Society; Health Protection Agency. Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society; British Thoracic Society; Health Protection Agency in collaboration with the Department of Health. Thorax 2007;62(Suppl 1):1-46.